01 September 2022>: Clinical Research
High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy
Iwona Homa-Mlak 1ACDEF* , Radosław Mlak 1ACDEF , Anna Brzozowska 2BDF , Marcin Mazurek 1CEF , Tomasz Powrózek 1CDF , Monika Prendecka-Wróbel 1CEF , Aneta Szudy-Szczyrek 2ADE , Piotr Dreher 3CEF , Katarzyna Kamińska 4F , Teresa Małecka-Massalska 1ACEF , Alicja Wójcik-Załuska 5CEGDOI: 10.12659/MSM.936857
Med Sci Monit 2022; 28:e936857
Table 1 Characteristic of the study group.
Factor | Study group (n=50) | |
---|---|---|
Gender | Male | 44 (88%) |
Female | 6 (12%) | |
Age (years) | ≥65 | 21 (42%) |
29 (58%) | ||
Histopathological diagnosis | Carcinoma planoepitheliale | 46 (92%) |
Other | 4 (8%) | |
Tumor location | Upper and middle | 11 (22%) |
Lower | 39 (78%) | |
Lower and middle | 45 (90%) | |
Upper | 5 (10%) | |
T stage | T1–T2 | 10 (20%) |
T3–T4 | 40 (80%) | |
N stage | N0 | 16 (32%) |
N1–N3 | 34 (68%) | |
M stage | Mx | 2 (4%) |
M0 | 47 (94%) | |
M1 | 1 (2%) | |
Performance status (ECOG) | 1 | 46 (92%) |
2 | 4 (8%) | |
Alcohol consumption | Yes | 21 (42%) |
No | 29 (58%) | |
Tobacco smoking | Yes | 42 (84%) |
No | 8 (16%) | |
ECOG – Eastern Cooperative Oncology Group; M – metastatic spread; N – lymph node involvement; T – tumor site and size; TNM – Tumor, Node, Metastasis staging. |